Sectors

PAHC
Phibro Animal Health Corporation
57.07
2 x 40.76
2 x 71.46
bid
ask
+
3.19
5.92%
2 @ 04:00 PM
56.95 -0.12 (0.21%)
Ytd 52.76%
1y 230.08%
54.50
day range
57.48
16.16
52 week range
60.08
Open 54.99 Prev Close 53.88 Low 54.50 High 57.48 Mkt Cap 2.31B
Vol 172.52K Avg Vol 293.98K EPS 2.26 P/E 25.25 Forward P/E 15.90
Beta 0.69 Short Ratio 4.82 Inst. Own 96.87% Dividend 0.48 Div Yield 0.87
Ex Div Date 03-04 Earning 05-06 50-d Avg 53.28 200-d Avg 41.36 1yr Est 51.20
Earning
Date For Estimate Reported Surprise surprise %
2026-05-06 2026-03 0.72 N/A N/A N/A
2026-02-04 2025-12 0.69 0.87 0.18 26.09%
2025-11-05 2025-09 0.59 0.73 0.14 23.73%
2025-08-27 2025-06 0.52 0.57 0.05 9.62%
2025-05-07 2025-03 0.52 0.63 0.11 21.15%
2025-02-05 2024-12 0.42 0.54 0.12 28.57%
Upgrade / Downgrade
Date Firm Action From To
2026-04-15 Citigroup Upgrade Neutral
2025-11-07 JP Morgan Upgrade Overweight Overweight
2025-08-29 B of A Securities Upgrade Underperform Underperform
2025-07-07 JP Morgan Upgrade Neutral Overweight
2025-06-25 Morgan Stanley Upgrade Equal-Weight Equal-Weight
2025-05-08 Morgan Stanley Upgrade Equal-Weight Equal-Weight
Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Insider Holder
Date Name Relation Quantity Description
2025-08-14 ANDOLINO ANTHONY Officer and Treasurer 1.79K Stock Award(Grant)
2025-08-14 BENDHEIM DANIEL M Officer and Director 3.96K Stock Award(Grant)
2026-04-15 BENDHEIM JACK C Chief Executive Officer 0.00 Sale
2026-03-30 BENDHEIM JACK CLIFFORD Chief Executive Officer 0.00 Sale
2025-08-14 BENDHEIM JONATHAN Director 3.27K Stock Award(Grant)
2025-02-23 CORCORAN E. THOMAS Director 30.00K Purchase
Institution Ownership
Report Date Organization Position Value Percentage
2025-12-30 Blackrock Inc. 3.35M 190.93M 16.22%
2025-12-30 Vanguard Group Inc 1.54M 87.86M 7.47%
2025-12-30 State Street Corporation 942.28K 53.78M 4.57%
2025-12-30 Acadian Asset Management. LLC 702.65K 40.10M 3.41%
2025-12-30 FMR, LLC 688.62K 39.30M 3.34%
2025-12-30 Millennium Management Llc 641.31K 36.60M 3.11%
Fund Ownership
Report Date Organization Position Value Percentage
2026-02-27 iShares Trust-iShares Core S&P Small-Cap ETF 1.24M 71.02M 6.03%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund 639.23K 36.48M 3.10%
2026-01-30 iShares Trust-iShares Russell 2000 ETF 484.74K 27.66M 2.35%
2026-02-27 Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total 380.14K 21.69M 1.84%
2025-12-30 VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund 221.06K 12.62M 1.07%
2025-12-30 OBERWEIS FUNDS-Oberweis Micro-Cap Fund 204.80K 11.69M 0.99%
Dividend
Dividend Date
0.12 2026-03-04
0.12 2025-11-26
0.12 2025-09-03
0.12 2025-06-04
0.12 2025-03-05
0.12 2024-11-27